There are 2789 resources available
443P - EMERGE: A phase II trial assessing the efficacy of domatinostat plus avelumab in patients with previously treated advanced mismatch repair proficient oesophagogastric and colorectal cancers – phase IIA dose finding
Presenter: Elizabeth Cartwright
Session: ePoster Display
483P - The correlation analysis between MUC16 mutation and immunotherapy predictive biomarkers in colon adenocarcinoma
Presenter: Gong Chen
Session: ePoster Display
354P - Extended dosing (12 cycles) vs. conventional dosing (6 cycles) of adjuvant temozolomide in adults with newly diagnosed high grade gliomas: A randomized, single-blind, two-arm, parallel-group controlled trial
Presenter: Seyed Alireza Javadinia
Session: ePoster Display
355P - Butterfly glioblastoma: Treatment strategies and clinical outcome
Presenter: Line Bjorland
Session: ePoster Display
Resources:
Abstract
356P - Redo surgery in relapsed glioblastoma multiforme: A comparative cohort analysis of a single institution experience
Presenter: Selvaraj Giridharan
Session: ePoster Display
357P - A phase II study of anlotinib in the treatment of recurrent high-grade glioma
Presenter: Hui Dai
Session: ePoster Display
358P - Anlotinib plus temozolomide for recurrent glioma: A single-center, retrospective study of 30 cases
Presenter: Yuandong Cao
Session: ePoster Display
359P - Regorafenib in recurrent glioblastoma patients: A large real-life experience
Presenter: Giuseppe Lombardi
Session: ePoster Display
360P - Metronomic temozolomide therapy in heavily pretreated patients with recurrent glioblastoma: A large mono-institutional retrospective study
Presenter: Vittorina Zagonel
Session: ePoster Display
361P - Efficacy of chemotherapy plus bevacizumab in recurrent multiforme glioblastoma: A real-life study
Presenter: Alexandre Beige
Session: ePoster Display